Lawrence Korngut

4.0k total citations
77 papers, 1.6k citations indexed

About

Lawrence Korngut is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Lawrence Korngut has authored 77 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 20 papers in Genetics and 16 papers in Molecular Biology. Recurrent topics in Lawrence Korngut's work include Amyotrophic Lateral Sclerosis Research (29 papers), Neurogenetic and Muscular Disorders Research (19 papers) and Parkinson's Disease Mechanisms and Treatments (12 papers). Lawrence Korngut is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (29 papers), Neurogenetic and Muscular Disorders Research (19 papers) and Parkinson's Disease Mechanisms and Treatments (12 papers). Lawrence Korngut collaborates with scholars based in Canada, United States and United Kingdom. Lawrence Korngut's co-authors include Nathalie Jetté, Tamara Pringsheim, Jean K. Mah, Lundy Day, Jonathan Dykeman, Lorne Zinman, Angela Genge, Sanjay Kalra, Cory Toth and Kirsten M. Fiest and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Brain.

In The Last Decade

Lawrence Korngut

70 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence Korngut Canada 18 617 423 305 284 253 77 1.6k
Jennifer Fine United States 19 684 1.1× 478 1.1× 115 0.4× 249 0.9× 140 0.6× 43 2.8k
Xiaodan Liu China 21 347 0.6× 221 0.5× 264 0.9× 222 0.8× 271 1.1× 97 1.8k
Maria Laura Manca Italy 25 623 1.0× 621 1.5× 194 0.6× 364 1.3× 295 1.2× 80 2.3k
Jenna Collins United States 14 278 0.5× 528 1.2× 305 1.0× 307 1.1× 86 0.3× 33 1.7k
Steven P. Ringel United States 28 713 1.2× 650 1.5× 245 0.8× 313 1.1× 400 1.6× 80 2.2k
David A. Price United States 32 699 1.1× 139 0.3× 149 0.5× 229 0.8× 202 0.8× 89 4.1k
Wildon Farwell United States 26 1000 1.6× 235 0.6× 1.0k 3.3× 220 0.8× 75 0.3× 91 3.1k
Necati Gökmen Türkiye 19 319 0.5× 206 0.5× 291 1.0× 227 0.8× 196 0.8× 85 2.1k
Fernando D. Testai United States 28 627 1.0× 982 2.3× 97 0.3× 225 0.8× 138 0.5× 123 2.6k
Jason C. Simeone United States 19 254 0.4× 567 1.3× 304 1.0× 298 1.0× 71 0.3× 40 1.8k

Countries citing papers authored by Lawrence Korngut

Since Specialization
Citations

This map shows the geographic impact of Lawrence Korngut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Korngut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Korngut more than expected).

Fields of papers citing papers by Lawrence Korngut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Korngut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Korngut. The network helps show where Lawrence Korngut may publish in the future.

Co-authorship network of co-authors of Lawrence Korngut

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Korngut. A scholar is included among the top collaborators of Lawrence Korngut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Korngut. Lawrence Korngut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Korngut, Lawrence, et al.. (2025). A toolkit for new facioscapulohumeral muscular dystrophy trial sites. Journal of Neuromuscular Diseases. 708706380–708706380.
2.
Hodgkinson, Victoria, G Westbury, Lawrence Korngut, et al.. (2024). A Study on the Incidence and Prevalence of 5q Spinal Muscular Atrophy in Canada Using Multiple Data Sources. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51(5). 660–671. 4 indexed citations
3.
Béland, Benjamin, et al.. (2024). No sex‐based differences in odds of starting or time to treatment of generalized myasthenia gravis: A single center cohort study. Muscle & Nerve. 70(4). 774–781. 2 indexed citations
4.
Benatar, Michael, Hannah Briemberg, Annie Dionne, et al.. (2024). Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathology. Journal of Neurology. 271(5). 2547–2559. 1 indexed citations
5.
Kushol, Rafsanjany, Collin Luk, Michael Benatar, et al.. (2023). SF2Former: Amyotrophic lateral sclerosis identification from multi-center MRI data using spatial and frequency fusion transformer. Computerized Medical Imaging and Graphics. 108. 102279–102279. 11 indexed citations
6.
Luk, Collin, Abdullah Ishaque, Peter Seres, et al.. (2022). Motor cortex functional connectivity is associated with underlying neurochemistry in ALS. Journal of Neurology Neurosurgery & Psychiatry. 94(3). 193–200. 10 indexed citations
7.
Frost, Geoffrey, et al.. (2022). Gold Coast criteria expand clinical trial eligibility in amyotrophic lateral sclerosis. Muscle & Nerve. 66(4). 397–403. 11 indexed citations
8.
Bharti, Komal, Simon J. Graham, Michael Benatar, et al.. (2022). Functional alterations in large-scale resting-state networks of amyotrophic lateral sclerosis: A multi-site study across Canada and the United States. PLoS ONE. 17(6). e0269154–e0269154. 18 indexed citations
9.
Hodgkinson, Victoria, Bernard Brais, Kristine Chapman, et al.. (2021). A Canadian Adult Spinal Muscular Atrophy Outcome Measures Toolkit: Results of a National Consensus using a Modified Delphi Method. Journal of Neuromuscular Diseases. 8(4). 579–588. 14 indexed citations
10.
Dadar, Mahsa, Ana L. Manera, Lorne Zinman, et al.. (2020). Cerebral atrophy in amyotrophic lateral sclerosis parallels the pathological distribution of TDP43. Brain Communications. 2(2). fcaa061–fcaa061. 29 indexed citations
11.
Statland, Jeffrey, Anthony A. Amato, Elena Bravver, et al.. (2018). Preliminary Results from a Phase 2 Study to Evaluate ACE-083, a Local Muscle Therapeutic, in Patients with Facioscapulohumeral Muscular Dystrophy (S38.001). Neurology. 90(15_supplement). 4 indexed citations
12.
McCormick, Anna, Alex MacKenzie, Erin O’Ferrall, et al.. (2017). The Canadian Neuromuscular Disease Registry: Connecting patients to national and international research opportunities. Paediatrics & Child Health. 23(1). 20–26. 11 indexed citations
13.
Patten, Scott B., Dina Aggad, J. Ricardo Martinez, et al.. (2017). Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis. JCI Insight. 2(22). 81 indexed citations
14.
Tarnopolsky, Mark A., Hans Katzberg, Basil J. Petrof, et al.. (2016). Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 43(4). 472–485. 45 indexed citations
15.
Mah, Jean K., Lawrence Korngut, Kirsten M. Fiest, et al.. (2015). A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 43(1). 163–177. 135 indexed citations
16.
Mah, Jean K., Lawrence Korngut, Jonathan Dykeman, et al.. (2014). A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscular Disorders. 24(6). 482–491. 346 indexed citations
17.
Alanazy, Mohammed H., Chris White, & Lawrence Korngut. (2014). Diagnostic yield and cost-effectiveness of investigations in patients presenting with isolated lower motor neuron signs. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15(5-6). 414–419. 5 indexed citations
18.
Hamilton, Mark G., Angela Genge, Megan Johnston, et al.. (2013). Patient Recruitment by Neurological Registries. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 40(S2). S23–S26. 7 indexed citations
19.
Mah, Jean K., Ruth Hall, Eric E. Smith, et al.. (2013). Evaluation of Neurological Patient Registries. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 40(S2). S60–S61. 2 indexed citations
20.
Pringsheim, Tamara, Darren Lam, Lundy Day, et al.. (2013). Validation and Interpretation of Neurological Registry Data. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 40(S2). S51–S53. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Fine Breakdown of academic impact, for papers by Xiaodan Liu Breakdown of academic impact, for papers by Maria Laura Manca Breakdown of academic impact, for papers by Jenna Collins Breakdown of academic impact, for papers by Steven P. Ringel Breakdown of academic impact, for papers by David A. Price Breakdown of academic impact, for papers by Wildon Farwell Breakdown of academic impact, for papers by Necati Gökmen Breakdown of academic impact, for papers by Fernando D. Testai Breakdown of academic impact, for papers by Jason C. Simeone
Rankless by CCL
2026